Contreras, C. F., Higham, C. S., Behnert, A., Kim, K., Stieglitz, E., & Tasian, S. K. (2020). Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children with Relapsed or Refractory B-Acute Lymphoblastic Leukemia. Pediatr Blood Cancer.
Citação norma ChicagoContreras, Cristina F., Christine S. Higham, Astrid Behnert, Kailyn Kim, Elliot Stieglitz, and Sarah K. Tasian. "Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children With Relapsed or Refractory B-Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2020.
MLA CitationContreras, Cristina F., et al. "Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children With Relapsed or Refractory B-Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2020.